Established cancer cell lines often fail to reflect the histological and functional features of primary human tumors in contrast to cell cultures derived from primary tumors. However, the derivation of primary tumor cell cultures is challenging.
This webinar covers our latest solutions for improved culture of primary and xenotransplanted tumor cells. We will take a look at our comprehensive cancer research workflow and share insights into:
David J. Agorku received his MS in Molecular Life Sciences from the HAN University of Applied Sciences of Nijmegen, the Netherlands, in 2019. In 2015, he joined Miltenyi Biotec in his role as Team Coordinator R&D for Cancer Research and he is currently continuing his studies on the topic as doctoral student.
Access online courses anytime, anywhere.
Become an expert in standard and innovative applications.
Acquire broad expertise and a comprehensive skill set.